Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Social Cognition in a Research Domain Criteria Perspective: A Bridge Between Schizophrenia and Autism Spectra Disorders. | Front Psychiatry | 2020 | 33005149 | PubTator, text mining | PubMed |
| Hypoxia in utero increases the risk of pulmonary hypertension in rat offspring and is associated with vasopressin type‑2 receptor upregulation. | Mol Med Rep | 2020 | 33000260 | PubTator, text mining | PubMed |
| Novel variant in the CNNM2 gene associated with dominant hypomagnesemia. | PLoS One | 2020 | 32997713 | PubTator, text mining | PubMed |
| The impact of metal coordination on the assembly of bis(indolyl)methane-naphthalene-diimide amphiphiles. | Dalton Trans | 2020 | 32996499 | PubTator, text mining | PubMed |
| AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions. | Cells | 2020 | 32993088 | PubTator, text mining | PubMed |
| Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme. | Int J Nanomedicine | 2020 | 32982226 | PubTator, text mining | PubMed |
| DeSiphering receptor core-induced and ligand-dependent conformational changes in arrestin via genetic encoded trimethylsilyl 1H-NMR probe. | Nat Commun | 2020 | 32978402 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Dependent Cross-Talk in Cancer-Focus on Pancreatic Cancer. | Front Oncol | 2020 | 32974169 | PubTator, text mining | PubMed |
| Description of a novel SLC34A3.c.671delT mutation causing hereditary hypophosphatemic rickets with hypercalciuria in two adolescent boys and response to recombinant human growth hormone. | Ther Adv Musculoskelet Dis | 2020 | 32963591 | PubTator, text mining | PubMed |
| Deciphering the Underlying Mechanism of Eucommiae Cortex against Osteoporotic Fracture by Network Pharmacology. | Evid Based Complement Alternat Med | 2020 | 32963568 | PubTator, text mining | PubMed |
| Distribution and relative expression of vasoactive receptors on arteries. | Sci Rep | 2020 | 32958803 | PubTator, text mining | PubMed |
| Estimation of Changes in Kidney Volume Growth Rate in ADPKD. | Kidney Int Rep | 2020 | 32954070 | PubTator, text mining | PubMed |
| A Provincial Survey of the Contemporary Management of Autosomal Dominant Polycystic Kidney Disease. | Can J Kidney Health Dis | 2020 | 32953126 | PubTator, text mining | PubMed |
| Exploring GPCR-arrestin interfaces with genetically encoded crosslinkers. | EMBO Rep | 2020 | 32929862 | PubTator, text mining | PubMed |
| A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus. | Am J Physiol Renal Physiol | 2020 | 32924547 | PubTator, text mining | PubMed |
| Distinct phosphorylation sites in a prototypical GPCR differently orchestrate β-arrestin interaction, trafficking, and signaling. | Sci Adv | 2020 | 32917711 | PubTator, text mining | PubMed |
| Is Oxytocin "Nature's Medicine"? | Pharmacol Rev | 2020 | 32912963 | PubTator, text mining | PubMed |
| Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease. | Clin Kidney J | 2020 | 32905289 | PubTator, text mining | PubMed |
| Identification of a Novel Arginine Vasopressin Receptor 2 Mutation (p.V183M) in a Chinese Family with Nephrogenic Diabetes Insipidus. | Mol Syndromol | 2020 | 32903920 | PubTator, text mining | PubMed |
| Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE. | Clin Genet | 2020 | 32901917 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=48